{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:06:33Z","timestamp":1744430793598,"version":"3.40.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,11]]},"DOI":"10.7759\/cureus.82057","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:45:46Z","timestamp":1744361146000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Clinicopathological Response to Neoadjuvant Chemotherapy in Patients Diagnosed With Locally Advanced Breast Carcinoma"],"prefix":"10.7759","author":[{"given":"Avegu","family":"Balji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhakrishna","family":"Ramchandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Ramchandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Chowhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashwant","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold M","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, et al.. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022, 66:15-23. 10.1016\/j.breast.2022.08.010","journal-title":"Breast"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00071-1","article-title":"The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases","volume":"22","author":"Anderson BO","year":"2021","unstructured":"Anderson BO, Ilbawi AM, Fidarova E, Weiderpass E, Stevens L, Abdel-Wahab M, Mikkelsen B. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases. Lancet Oncol. 2021, 22:578-81. 10.1016\/S1470-2045(21)00071-1","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1984.112","article-title":"Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination","volume":"49","author":"Koscielny S","year":"1984","unstructured":"Koscielny S, Tubiana M, L\u00ea MG, Valleron AJ, Mouriesse H, Contesso G, Sarrazin D. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer. 1984, 49:709-15. 10.1038\/bjc.1984.112","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1178223420980377","article-title":"Neoadjuvant chemotherapy for breast cancer: past, present, and future","volume":"14","author":"Asaoka M","year":"2020","unstructured":"Asaoka M, Gandhi S, Ishikawa T, Takabe K. Neoadjuvant chemotherapy for breast cancer: past, present, and future. Breast Cancer (Auckl). 2020, 14:1178223420980377. 10.1177\/1178223420980377","journal-title":"Breast Cancer (Auckl)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2007.02.004","article-title":"Neoadjuvant systemic therapy and the surgical management of breast cancer","volume":"87","author":"Waljee JF","year":"2007","unstructured":"Waljee JF, Newman LA. Neoadjuvant systemic therapy and the surgical management of breast cancer. Surg Clin North Am. 2007, 87:399-415. 10.1016\/j.suc.2007.02.004","journal-title":"Surg Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter CL","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989, 63:181-7. 10.1002\/1097-0142(19890101)63:1&lt;181::aid-cncr2820630129&gt;3.0.co;2-h","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF00121498","article-title":"T3b-T4 breast cancer: factors affecting results in combined modality treatments","volume":"1","author":"Valagussa P","year":"1983","unstructured":"Valagussa P, Zambetti M, Bignami P, et al.. T3b-T4 breast cancer: factors affecting results in combined modality treatments. Clin Exp Metastasis. 1983, 1:191-202. 10.1007\/BF00121498","journal-title":"Clin Exp Metastasis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.12.011","article-title":"Locally advanced breast cancer","volume":"62","author":"Aebi S","year":"2022","unstructured":"Aebi S, Karlsson P, Wapnir IL. Locally advanced breast cancer. Breast. 2022, 62:S58-62. 10.1016\/j.breast.2021.12.011","journal-title":"Breast"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.25223","article-title":"Breast cancer staging: updates in the AJCC cancer staging manual, 8th edition, and current challenges for radiologists, from the AJR special series on cancer staging","volume":"217","author":"Teichgraeber DC","year":"2021","unstructured":"Teichgraeber DC, Guirguis MS, Whitman GJ. Breast cancer staging: updates in the AJCC cancer staging manual, 8th edition, and current challenges for radiologists, from the AJR special series on cancer staging. AJR Am J Roentgenol. 2021, 217:278-90. 10.2214\/AJR.20.25223","journal-title":"AJR Am J Roentgenol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1957.43","article-title":"Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years","volume":"11","author":"Bloom HJ","year":"1957","unstructured":"Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957, 11:359-77. 10.1038\/bjc.1957.43","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S277588","article-title":"A study on clinical and pathological responses to neoadjuvant chemotherapy in breast carcinoma","volume":"12","author":"Kunnuru SK","year":"2020","unstructured":"Kunnuru SK, Thiyagarajan M, Martin Daniel J, Singh K B. A study on clinical and pathological responses to neoadjuvant chemotherapy in breast carcinoma. Breast Cancer (Dove Med Press). 2020, 12:259-66. 10.2147\/BCTT.S277588","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0969","article-title":"Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation","volume":"164","author":"Nelson HD","year":"2016","unstructured":"Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2016, 164:244-55. 10.7326\/M15-0969","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2497-y","article-title":"The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients","volume":"138","author":"Hurley J","year":"2013","unstructured":"Hurley J, Reis IM, Rodgers SE, et al.. The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients. Breast Cancer Res Treat. 2013, 138:783-94. 10.1007\/s10549-013-2497-y","journal-title":"Breast Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3259.ijct20200204","article-title":"Evaluation of neo adjuvant chemotherapy response in patients with locally advanced breast cancer","volume":"7","author":"Krishna NM","year":"2020","unstructured":"Krishna NM, Mani CM, Veera AC, Chandra TJ. Evaluation of neo adjuvant chemotherapy response in patients with locally advanced breast cancer. Int J Clin Trials. 2020, 7:32-4. 10.18203\/2349-3259.ijct20200204","journal-title":"Int J Clin Trials"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS18-PD8-04","article-title":"Abstract PD8-04: neoadjuvant chemotherapy for breast cancer: nodal downstaging is highly correlated with pathological complete response","volume":"79","author":"Blumencranz P","year":"2019","unstructured":"Blumencranz P, Habibi M, Treece T, et al.. Abstract PD8-04: neoadjuvant chemotherapy for breast cancer: nodal downstaging is highly correlated with pathological complete response. Cancer Res. 2019, 79:PD8-04. 10.1158\/1538-7445.SABCS18-PD8-04","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2298\/AOO190128001A","article-title":"Assessment of pathological response to neoadjuvant chemotherapy in patients with breast carcinoma using Sataloff system","volume":"25","author":"Agarwal S","year":"2019","unstructured":"Agarwal S, Pandey P, Ralli M, Chaturvedi V, Mittal K, Singh S. Assessment of pathological response to neoadjuvant chemotherapy in patients with breast carcinoma using Sataloff system. Arch Oncol. 2019, 25:13-8. 10.2298\/AOO190128001A","journal-title":"Arch Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20210114","article-title":"Factors affecting pathological complete response after neoadjuvant chemotherapy in breast cancer: a single-center experience","volume":"67","author":"Mermut O","year":"2021","unstructured":"Mermut O, Inanc B, Gursu RU, Arslan E, Trabulus DC, Havare SB, Ulusan MB. Factors affecting pathological complete response after neoadjuvant chemotherapy in breast cancer: a single-center experience. Rev Assoc Med Bras (1992). 2021, 67:845-50. 10.1590\/1806-9282.20210114","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9644-2","article-title":"Assessment of clinical response after two cycles of primary chemotherapy in breast cancer","volume":"109","author":"Beresford MJ","year":"2008","unstructured":"Beresford MJ, Stott D, Makris A. Assessment of clinical response after two cycles of primary chemotherapy in breast cancer. Breast Cancer Res Treat. 2008, 109:337-42. 10.1007\/s10549-007-9644-2","journal-title":"Breast Cancer Res Treat"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v24i1.2","article-title":"Evaluation of clinical and pathological response after two cycles of neoadjuvant chemotherapy on Sudanese patients with locally advanced breast cancer","volume":"24","author":"Alawad AA","year":"2014","unstructured":"Alawad AA. Evaluation of clinical and pathological response after two cycles of neoadjuvant chemotherapy on Sudanese patients with locally advanced breast cancer. Ethiop J Health Sci. 2014, 24:15-20. 10.4314\/ejhs.v24i1.2","journal-title":"Ethiop J Health Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2022\/52512.15919","article-title":"Evaluation of clinical and pathological response in breast cancer following neoadjuvant chemotherapy- a single institution experience","volume":"16","author":"Gafoor AF","year":"2022","unstructured":"Gafoor AF, Balakrishnan P, Krishna KJ, Arjunan A. Evaluation of clinical and pathological response in breast cancer following neoadjuvant chemotherapy- a single institution experience. J Clin Diagn Res. 2022, 16:XC01-05. 10.7860\/JCDR\/2022\/52512.15919","journal-title":"J Clin Diagn Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600749","article-title":"Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome","volume":"88","author":"Faneyte IF","year":"2003","unstructured":"Faneyte IF, Schrama JG, Peterse JL, Remijnse PL, Rodenhuis S, van de Vijver MJ. Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome. Br J Cancer. 2003, 88:406-12. 10.1038\/sj.bjc.6600749","journal-title":"Br J Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000322192","article-title":"Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer","volume":"79","author":"Kim SI","year":"2010","unstructured":"Kim SI, Sohn J, Koo JS, Park SH, Park HS, Park BW. Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Oncology. 2010, 79:324-30. 10.1159\/000322192","journal-title":"Oncology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323970-assessment-of-clinicopathological-response-to-neoadjuvant-chemotherapy-in-patients-diagnosed-with-locally-advanced-breast-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:45:46Z","timestamp":1744361146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323970-assessment-of-clinicopathological-response-to-neoadjuvant-chemotherapy-in-patients-diagnosed-with-locally-advanced-breast-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.82057","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}